Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
SANOFI.NSthis companySanofi India Limited	₹3,329.30	28.81×	12.56×	5.12×	18.93×	23.4%	39.1%	24.7%	17.8%	43.6%	43.5%	4.5%	0.02×	-0.53×	267.06×	1.63×	4.7%	4	10.83	2	C+
ABBOTINDIA.NSAbbott India Limited	₹26,680.00	35.48×	11.53×	7.95×	24.37×	179.8%	36.2%	26.5%	22.4%	32.5%	27.0%	3.0%	0.04×	-0.96×	97.31×	2.55×	1.8%	4	22.4	2	C
ALKEM.NSAlkem Laboratories Limited	₹5,398.50	27.24×	4.54×	4.26×	18.9×	35.0%	65.4%	17.8%	15.6%	16.7%	12.5%	2.1%	0.15×	0.53×	16.32×	2.55×	1.0%	3	—	2	B-
APLLTD.NSAlembic Pharmaceuticals Limited	₹1,017.30	19.32×	2.3×	1.77×	12.9×	3.1%	45.1%	10.9%	9.2%	11.9%	10.4%	2.0%	0.25×	1.11×	8.54×	1.76×	1.7%	4	—	2	B-
ASTRAZEN.NSAstraZeneca Pharma India Limited	₹6,529.00	103.53×	22.24×	8.53×	66.87×	74.4%	26.5%	10.3%	8.2%	21.5%	17.0%	0.0%	0.13×	-1.18×	51.99×	1.77×	0.4%	3	—	2	C+
CIPLA.NSCipla Limited	₹1,403.80	25.49×	2.87×	3.51×	15.19×	112.4%	42.7%	16.7%	13.8%	11.3%	9.8%	2.6%	0.02×	-0.06×	86.67×	3.44×	1.3%	4	9.92	4	A-
Peer median	—	27.24×	4.54×	4.26×	18.9×	74.4%	42.7%	16.7%	13.8%	16.7%	12.5%	2.1%	0.13×	-0.06×	51.99×	2.55×	1.3%	4	16.16	2	—